Supported by

Tricuspid / Pulmonary valve

Find all the latest content on tricuspid or pulmonary valve published on this website.

Endovascular treatments for complications of the tricuspid or pulmonary valve, such as the treatment for tricuspid regurgitation (TR), are at an early stage of clinical development with many novel devices being introduced each year. This topic explores the different parameters of this emerging field with information on the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Tricuspid / Pulmonary valve

475 results

The many faces of TTVR

21 May 2025 – From EuroPCR 2025

Discover the diverse clinical scenarios of transcatheter tricuspid valve replacement (TTVR). This session presents complex cases including acute right ventricular afterload mismatch, combined pulmonary and tricuspid valve interventions in carcinoid heart disease, and challenges in dilated cava anatomy, showcasing the expanding frontiers of TTVR therapy.

The many faces of TTVR

Transcatheter tricuspid valve replacement in the real world: current data and outcomes

21 May 2025 – From EuroPCR 2025

Explore current real-world data and outcomes of transcatheter tricuspid valve replacement (TTVR). This session reviews UK single-centre experiences, registry data, long-term right ventricular remodeling effects, safety in pacemaker patients, and AI-based CT screening for patient selection.

Transcatheter tricuspid valve replacement in the real world: current data and outcomes

How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?

21 May 2025 – From EuroPCR 2025

Learn how to select appropriate cardiovascular interventions for tricuspid regurgitation patients by considering comorbidities, anatomical factors influencing procedural success, and imaging criteria for device selection. The session includes patient vignettes to illustrate decision-making pathways.

How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?

Right ventricule and tricuspid regurgitation: a linked faith

21 May 2025 – From EuroPCR 2025

Investigate the interconnected pathophysiology of right ventricular function and tricuspid regurgitation. This session reviews predictors of outcomes post-transcatheter tricuspid valve repair, the impact of disproportionate regurgitation, and changes in ventricular contraction patterns.

Right ventricule and tricuspid regurgitation: a linked faith

Right heart catheterisation and CT scan for the assessment of A-V valve treated percutaneously

21 May 2025 – From EuroPCR 2025

This session evaluates right heart catheterisation and cardiac CT imaging in the assessment of percutaneously treated atrioventricular valves. Explore clinical outcomes, invasive physiology characterization, annular remodeling, and pulmonary hypertension impact on mitral and tricuspid valve interventions.

Right heart catheterisation and CT scan for the assessment of A-V valve treated percutaneously

Therapeutic choices for TTVIV-TTVIR interventions

21 May 2025 – From EuroPCR 2025

Explore therapeutic choices for transcatheter tricuspid valve-in-valve and valve-in-ring interventions. Case studies cover annular ring expansion, pacing-related infection, jugular vein access valve replacement, Ebstein anomaly, and double valve-in-valve procedures in right heart disease.

Therapeutic choices for TTVIV-TTVIR interventions

EuroPCR 2025: Cutting through the complexity

20 May 2025

Complexity is the fil rouge of this year’s course but what does it mean to the Course Directors? And how can EuroPCR help participants cut through the complexity?

EuroPCR 2025: Cutting through the complexity

PCR's Got Talent Round 1 - Session 1

20 May 2025 – From EuroPCR 2025

Experience a diverse range of cutting-edge interventional cardiology topics in PCR's Got Talent Round 1. This session features presentations on PFO closure outcomes, plaque morphology, vascular injury treatments, microvascular disease assessment, TAVI-related coronary obstruction prediction, novel FFR surrogates, and more.

PCR's Got Talent Round 1 - Session 1

Pioneering innovation in the treatment of mitral and tricuspid regurgitation

20 May 2025 – From EuroPCR 2025

This interventional session explores therapeutic strategies for mitral and tricuspid regurgitation, focusing on the clinical decision-making process between repair and replacement. Through two clinical cases, a 78-year-old male patient with severe degenerative mitral regurgitation and an 88-year-old female patient with atrial functional mitral regurgitation, experts review available...

Pioneering innovation in the treatment of mitral and tricuspid regurgitation

PCR's Got Talent Round 1 - Session 2

20 May 2025 – From EuroPCR 2025

Join the dynamic PCR's Got Talent Round 1 - Session 2 featuring cutting-edge research and innovations in interventional cardiology. Highlights include complex CTO PCI strategies, valve comparisons in TAVI for small annuli, PFO closure outcomes, long-term PCI durability, CT-guided robotic PCI, pacemaker prediction post-TAVI, and much...

PCR's Got Talent Round 1 - Session 2